Streetbeat News

Regulatory

NVDA

UNH

USO

Oil prices fell after reports that Israel would not target Iranian oil. Healthcare stocks, including UnitedHealth, declined following Q3 earnings. The Biden administration is considering restricting chip exports to certain countries.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 2:00 pm

AMD

BTCUSD

DOGEUSD

ETHUSD

NVDA

TSLA

Tesla has introduced a 7-seat Model Y in the Netherlands amid a slowdown in EV sales in Europe. Meanwhile, Bitcoin, Ethereum, and Dogecoin have surged as stocks hit record highs. The Nasdaq is nearing a record high, and oil prices have plummeted. Cathie Wood's Ark Invest sold $5.7M of Robinhood shares while buying AMD stock. Nvidia and AMD face potential export curbs as the Biden administration considers restrictions.

Portfolio Pulse from Akanksha Bakshi

October 15, 2024 | 1:46 pm

GS

Goldman Sachs CEO David Solomon highlighted significant pent-up demand from clients and an increase in deal backlog. The firm expects alternatives fundraising to exceed $60 billion in 2024. However, there are ongoing concerns about the regulatory process.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:36 pm

XRP

Ripple has launched a new U.S. dollar-pegged stablecoin, RLUSD, aimed at enterprise applications. This comes as World Liberty, backed by Donald Trump, endorses stablecoins over Bitcoin. RLUSD is designed for cross-border payments and is supported by major exchanges and market makers. The stablecoin is issued under a New York Trust Company Charter, ensuring regulatory compliance.

Portfolio Pulse from Benzinga Neuro

October 15, 2024 | 1:30 pm

GNPX

Genprex has advanced to the highest dose group in its Acclaim-3 trial for Reqorsa gene therapy, in combination with Tecentriq, after receiving approval from the Safety Review Committee.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:29 pm

CRML

Critical Metals Corp (NASDAQ:CRML) has advanced its Tanbreez Rare Earth Mine project in Greenland by securing an extension for its exclusive exploitation license and completing a diamond drilling program. Rare earth material samples have been sent for testing.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:26 pm

BAYRY

Bayer AG has submitted a marketing authorization application to the European Medicines Agency for its menopause drug elinzanetant, following positive Phase 3 trial results. The drug showed significant reduction in vasomotor symptoms and improved quality of life over 52 weeks.

Portfolio Pulse from Vandana Singh

October 15, 2024 | 1:26 pm

NRSN

NeuroSense Therapeutics Ltd. plans to submit a dossier for early commercialization of its ALS treatment, PrimeC, in Canada by Q2 2025, with a regulatory decision expected by Q1 2026. The company estimates a potential market opportunity of $100M-$150M in annual revenue.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:24 pm

ANVS

Annovis Bio's stock is rising following FDA clearance for Phase 3 Alzheimer's studies and alignment of Buntanetap NDAs.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:24 pm

GOOG

GOOGL

OKLO

Oklo Inc (NYSE:OKLO) shares are rising due to momentum from a Google nuclear deal and the U.S. Department of Energy's approval of Oklo's Aurora fuel fabrication facility design report. This positions Oklo for future advancements in nuclear energy.

Portfolio Pulse from Adam Eckert

October 15, 2024 | 1:16 pm